IQVIA vs Unlearn.AI
The largest agent platform in clinical development against the most rigorous single method in it. IQVIA launched a unified agentic platform in March 2026 spanning clinical, commercial and real world evidence work, names its infrastructure stack precisely and holds the most developed governance apparatus in this category. Unlearn does one thing with unusual discipline: digital twins of trial participants used as a prognostic covariate to reduce enrolment requirements, with published method transparency approaching an academic standard and a regulatory achievement unique in this index. They are complementary, since one changes the protocol and the other runs the operation around it. The question to put to IQVIA is which of its several relationships to your data governs which capability, because it does not say.
- Its March 2026 agentic platform spans clinical, commercial and real world evidence operations with a marketplace, and the infrastructure stack is named precisely.
- The governance apparatus is the most developed in this category and includes a concrete architectural control rather than a principles page.
- For a sponsor already working across trial operations with the organisation, the agents arrive inside an existing relationship.
- Method transparency approaches an academic standard, with the procedure published and the statistical properties described rather than asserted.
- Its regulatory achievement is distinct from and arguably harder than a device clearance, and it is unique in this index.
- The autonomy question is solved by design rather than by policy, which is the most rigorous answer to it recorded here.
Side by Side
| Axis | I IQVIA |
U Unlearn.AI |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Trials AI page.
These operate at different points, one supplying agents and services across trial operations and the other changing the statistical design of the trial itself, so they are complementary rather than competing. Unlearn's evidence measures statistical efficiency rather than patient outcomes, which is the correct claim for what it does and should not be read as clinical benefit. IQVIA stands in several relationships to sponsor data at once, as service provider, data holder and software vendor, and does not state which governs which capability. Neither publishes pricing.